全文获取类型
收费全文 | 3741篇 |
免费 | 329篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 34篇 |
儿科学 | 114篇 |
妇产科学 | 84篇 |
基础医学 | 447篇 |
口腔科学 | 41篇 |
临床医学 | 470篇 |
内科学 | 662篇 |
皮肤病学 | 167篇 |
神经病学 | 302篇 |
特种医学 | 61篇 |
外科学 | 376篇 |
综合类 | 133篇 |
一般理论 | 6篇 |
预防医学 | 608篇 |
眼科学 | 37篇 |
药学 | 197篇 |
中国医学 | 3篇 |
肿瘤学 | 332篇 |
出版年
2023年 | 16篇 |
2022年 | 31篇 |
2021年 | 88篇 |
2020年 | 53篇 |
2019年 | 98篇 |
2018年 | 93篇 |
2017年 | 80篇 |
2016年 | 75篇 |
2015年 | 100篇 |
2014年 | 151篇 |
2013年 | 196篇 |
2012年 | 264篇 |
2011年 | 261篇 |
2010年 | 154篇 |
2009年 | 121篇 |
2008年 | 213篇 |
2007年 | 250篇 |
2006年 | 225篇 |
2005年 | 205篇 |
2004年 | 212篇 |
2003年 | 184篇 |
2002年 | 210篇 |
2001年 | 65篇 |
2000年 | 56篇 |
1999年 | 25篇 |
1998年 | 26篇 |
1997年 | 30篇 |
1996年 | 23篇 |
1995年 | 25篇 |
1994年 | 22篇 |
1993年 | 18篇 |
1992年 | 28篇 |
1991年 | 53篇 |
1990年 | 23篇 |
1989年 | 23篇 |
1988年 | 31篇 |
1987年 | 28篇 |
1986年 | 24篇 |
1985年 | 33篇 |
1984年 | 26篇 |
1983年 | 24篇 |
1980年 | 10篇 |
1979年 | 16篇 |
1978年 | 10篇 |
1974年 | 14篇 |
1973年 | 11篇 |
1971年 | 13篇 |
1970年 | 11篇 |
1969年 | 14篇 |
1968年 | 14篇 |
排序方式: 共有4074条查询结果,搜索用时 15 毫秒
91.
Trisha Suppes Terence A. Ketter Iola S. Gwizdowski Ellen B. Dennehy Shelley J. Hill E. Grace Fischer Diane E. Snow Robert Gonzalez Suresh Sureddi Geetha Shivakumar Victoria E. Cosgrove 《Journal of affective disorders》2013
Objectives
To compare the efficacy and safety of adjunctive quetiapine (QTP) versus placebo (PBO) for patients with bipolar II disorder (BDII) currently experiencing mixed hypomanic symptoms in a 2-site, randomized, placebo-controlled, double-blind, 8-week investigation.Methods
Participants included 55 adults (age 18–65 years) who met criteria for BDII on the Structured Clinical Interview for DSM-IV-TR (SCID). Entrance criteria included a stable medication regimen for ≥2 weeks and hypomania with mixed symptoms (>12 on the Young Mania Rating Scale [YMRS] and >15 on the Montgomery Asberg Depression Rating Scale [MADRS] at two consecutive visits 1–3 days apart). Participants were randomly assigned to receive adjunctive quetiapine (n=30) or placebo (n=25).Results
Adjunctive quetiapine demonstrated significantly greater improvement than placebo in Clinical Global Impression for Bipolar Disorder Overall Severity scores (F(1)=10.12, p=.002) and MADRS scores (F(1)=6.93, p=.0138), but no significant differences were observed for YMRS scores (F(1)=3.68, p=.069). Side effects of quetiapine were consistent with those observed in previous clinical trials, with sedation/somnolence being the most common, occurring in 53.3% with QTP and 20.0% with PBO.Conclusions
While QTP was significantly more effective than PBO for overall and depressive symptoms of BDII, there was no significant difference between groups in reducing symptoms of hypomania. Hypomania improved across both groups throughout the study. 相似文献92.
93.
Introduction: Closed head injury is associated with impairment in a range of executive skills, and with everyday difficulties in social interactions. Comprehension of pragmatic language plays an important role in social interactions. The present study was designed to examine performance on a task involving pragmatic judgement in people who had suffered closed head injury (CHI), and the relationship between this and any impairments in executive skills. Methods: Participants with CHI were compared to a matched healthy control group on a pragmatic inference task consisting of a series of brief vignettes. Participants made judgements about alternative responses in relation to social appropriateness/skill, and carried out several nonsocial executive tasks thought to play a role in pragmatic judgement. Results: The CHI group was poorer than the control group on the pragmatic measure, showing less discrimination than the control group between direct, literal interpretations and correct, indirect interpretations. They also performed more poorly on the nonsocial executive measures. Regression analysis showed an association between pragmatic performance and one of the executive tasks, a measure of inhibition. Conclusions: More work is needed to explore further the nature of any relationship between pragmatic judgement and executive skills. 相似文献
94.
95.
96.
97.
Shapiro S 《Current opinion in pulmonary medicine》2003,9(5):426-430
Pulmonary hypertension affects right ventricular function by imposing an afterload on the right ventricle and, therefore, as pulmonary hypertension worsens, it ultimately reduces cardiac output. It is clear that in interstitial lung disease, progression of the underlying process with the loss of lung parenchyma contributes substantially to outcome. However, the additional burden of pulmonary hypertension often results in rapid deterioration. Pulmonary hypertension may be treatable and thus may enable the patient to survive until other therapy is effective. Until recently, part of the hesitancy in treating pulmonary hypertension in patients with secondary pulmonary hypertension, has been the limited availability of oral or intravenous drugs that affect the pulmonary circuit without causing excessive systemic vasodilatation. The current drugs available for the treatment of pulmonary hypertension, including prostacyclin and endothelin receptor blockers, have been limited by their high costs and, in the case of prostacyclin, the drug delivery systems. Nitric oxide, which has been used both acutely and chronically for pulmonary hypertension in a variety of diseases, also has limited availability. The role of sildenafil and inhaled prostacyclin remains to be evaluated. The use of these agents in the setting of interstitial lung disease needs to be studied, including combination therapy and early initiation of therapy. Their effect on tissue damage, fibrosis, and inflammation needs to be assessed as well as their effect on the arteriopathy and their potential to cause ventilation-perfusion (V/Q) mismatching. There now appears to be evidence to support treating pulmonary hypertension in patients with interstitial lung disease, with a potential for clinical benefit and a molecular basis for doing it. 相似文献
98.
99.
Janet A. Hindler Annie Wong-Beringer Carmen L. Charlton Shelley A. Miller Theodoros Kelesidis Marissa Carvalho George Sakoulas Poochit Nonejuie Joseph Pogliano Victor Nizet Romney Humphries 《Antimicrobial agents and chemotherapy》2015,59(7):4279-4288
Enterococci that are nonsusceptible (NS; MIC > 4 μg/ml) to daptomycin are an emerging clinical concern. The synergistic combination of daptomycin plus beta-lactams has been shown to be effective against vancomycin-resistant Enterococcus (VRE) species in vitro. This study systematically evaluated by in vitro time-kill studies the effect of daptomycin in combination with ampicillin, cefazolin, ceftriaxone, ceftaroline, ertapenem, gentamicin, tigecycline, and rifampin, for a collection of 9 daptomycin-NS enterococci that exhibited a broad range of MICs and different resistance-conferring mutations. We found that ampicillin plus daptomycin yielded the most consistent synergy but did so only for isolates with mutations to the liaFSR system. Daptomycin binding was found to be enhanced by ampicillin in a representative isolate with such mutations but not for an isolate with mutation to the yycFGHIJ system. In contrast, ampicillin enhanced the killing of the LL-37 human antimicrobial peptide against daptomycin-NS E. faecium with either the liaFSR or yycFGHIJ mutation. Antagonism was noted only for rifampin and tigecycline and only for 2 or 3 isolates. These data add support to the growing body of evidence indicating that therapy combining daptomycin and ampicillin may be helpful in eradicating refractory VRE infections. 相似文献
100.
Zane Dodd Simon Driver Ann Marie Warren Shelley Riggs Mike Clark 《Topics in spinal cord injury rehabilitation》2015,21(2):156-165